Clinical trial
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
NCT03895437 is registered in ClinicalTrials.gov with Tolerion, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
- Lead sponsor
- Tolerion, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- June 17, 2019
- Completion date
- December 21, 2020
- Enrollment
- 78 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.